Literature DB >> 11396679

Severe brain atrophy in a case of thalamic variant of sporadic CJD with plaque-like PrP deposition.

M Yamashita1, T Yamamoto, K Nishinaka, F Udaka, M Kameyama, T Kitamoto.   

Abstract

A 30-year-old woman presented with ataxic gait and progressive mental deterioration, and 3 years later developed myoclonus in the limbs. Subsequently, she lapsed into an akinetic state and died more than 6 years after the onset of disease. The brain weighed 670 g, and preferential degeneration was found in the medial thalamus and the inferior olivary nucleus. In the cerebrum and cerebellum, gliosis and neuronal depletion were only mild and disintegration of the parenchymal structures was inconspicuous, despite pronounced atrophy. The patient had methionine homozygosity at codon 129 of the PrP gene and protease-resistant PrP type 2 in the brain. On PrP immunostaining, plaque-like deposits were detected in the cerebral and cerebellar cortices. Severe brain atrophy such as in the present case has never been described in the thalamic variant of sporadic CJD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396679     DOI: 10.1046/j.1440-1789.2001.00383.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  3 in total

1.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

2.  Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report.

Authors:  Karen M Moody; Lawrence B Schonberger; Ryan A Maddox; Wen-Quan Zou; Laura Cracco; Ignazio Cali
Journal:  BMC Neurol       Date:  2011-10-31       Impact factor: 2.474

3.  Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease.

Authors:  E Nakatani; Y Kanatani; H Kaneda; Y Nagai; S Teramukai; T Nishimura; B Zhou; S Kojima; H Kono; M Fukushima; T Kitamoto; H Mizusawa
Journal:  Eur J Neurol       Date:  2016-05-24       Impact factor: 6.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.